Clinical Analysis of Peripheral Blood Indicators for Immune-Related Adverse Events (irAEs) in Patients With Advanced Lung Cancer.

Clin Med Insights Oncol · 2026 · PMC12819973 · PMID 41574053

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In the Supplementary Figures 1 and 2 , it was reflected that during the progressive aggravation of CIP in 2 patients with advanced tumors, NLR and PLR also showed a trend of progressive increase.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.